BlackRock, Inc. 13D and 13G filings for Abbott Laboratories:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-01-26 11:49 am Sale | 2023-12-31 | 13G | Abbott Laboratories ABT | BlackRock Inc. BLK | 134,061,311 7.700% | -5,464,905 (-3.92%) | Filing |
| 2023-02-06 4:35 pm Purchase | 2022-12-31 | 13G | Abbott Laboratories ABT | BlackRock Inc. BLK | 139,526,216 8.000% | 2,370,614 (+1.73%) | Filing |
| 2022-01-31 5:49 pm Purchase | 2021-12-31 | 13G | Abbott Laboratories ABT | BlackRock Inc. BLK | 137,155,602 7.800% | 3,728,792 (+2.79%) | Filing |
| 2021-01-28 5:56 pm Purchase | 2020-12-31 | 13G | Abbott Laboratories ABT | BlackRock Inc. BLK | 133,426,810 7.500% | 8,698,208 (+6.97%) | Filing |
| 2020-02-05 11:25 am Purchase | 2019-12-31 | 13G | Abbott Laboratories ABT | BlackRock Inc. BLK | 124,728,602 7.100% | 3,683,012 (+3.04%) | Filing |